ZNF217 Recombinant Monoclonal Antibody
-
中文名稱:ZNF217 Recombinant Monoclonal Antibody
-
貨號(hào):CSB-RA074893A0HU
-
規(guī)格:¥1320
-
圖片:
-
Flow cytometric analysis of Zinc finger protein 217 expression in HAP-1 cells using Zinc finger protein 217 antibody. Green, isotype control; red, Zinc finger protein 217.
-
Immunocytochemical staining of HAP-1 cells with zinc finger protein 217 antibody. Nuclei were stained blue with DAPI; Zinc finger protein 217 was stained magenta with Alexa Fluor? 647. Images were taken using Leica stellaris 5. Protein abundance based on laser Intensity and smart gain: Medium. Scale bar: 20 μm.
-
Western blotting analysis using zinc finger protein 217 antibody. Total cell lysates (30 μg) from various cell lines were loaded and separated by SDS-PAGE. The blot was incubated with zinc finger protein 217 antibody and HRP-conjugated goat anti-rabbit secondary antibody respectively.
-
-
其他:
產(chǎn)品詳情
-
Uniprot No.:
-
基因名:ZNF217
-
別名:ZNF217; Zinc Finger Protein 217; ZABC1
-
反應(yīng)種屬:Human, Rat
-
免疫原:Recombinant Human ZNF217 protein
-
免疫原種屬:Homo sapiens (Human)
-
標(biāo)記方式:Non-conjugated
-
克隆類型:Monoclonal
-
抗體亞型:Rabbit IgG
-
純化方式:Affinity-chromatography
-
克隆號(hào):10D10
-
濃度:It differs from different batches. Please contact us to confirm it.
-
保存緩沖液:Rabbit IgG in PBS (pH 7.4) containing 50% glycerol, and 0.02% sodium azide.
-
產(chǎn)品提供形式:Liquid
-
應(yīng)用范圍:ELISA, WB, FC, ICC
-
推薦稀釋比:
Application Recommended Dilution WB 1:1000-1:5000 FC 1:200-1:2000 ICC 1:100-1:1000 -
Protocols:
-
儲(chǔ)存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關(guān)產(chǎn)品
靶點(diǎn)詳情
-
功能:Binds to the promoters of target genes and functions as repressor. Promotes cell proliferation and antagonizes cell death. Promotes phosphorylation of AKT1 at 'Ser-473'.
-
基因功能參考文獻(xiàn):
- this study underscored that elevated expression of ZNF217 promotes prostate cancer growth by restraining ferroportin -conducted iron egress PMID: 27768596
- this paper shows that hypoxia-inducible factors regulate pluripotency factor expression by ZNF217-mediated modulation of RNA methylation in breast cancer cells PMID: 27590511
- ZNF217 overexpression is associated with neoplasms. PMID: 27007163
- GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression. PMID: 27267060
- ZNF217 regulates N6-methyladenosine mRNA deposition in embryonic stem cells thus contributing to tumorigenesis by dysregulating gene expression programs. PMID: 27519282
- The report shows that the ZNF217 oncogene is a crucial mediator and indicator of bone metastasis from breast cancer. PMID: 28207159
- findings indicate that lncRNA-ATB governs the autocrine secretion of TGF-beta2 in KFs, at least in part, by downregulating the expression level of ZNF217 via miR-200c, suggesting a signaling axis consisting of lncRNA-ATB/miR-200c/ZNF217/TGF-beta2 PMID: 27090737
- Review: highlight the downstream molecular targets and signaling pathways of ZNF217 in tumor cells. PMID: 26431164
- High expression of ZNF217 is associated with enhanced cell migration and invasion in colorectal carcinoma. PMID: 25824781
- Two polymorphisms in ZNF217 in Mexican patients with colorectal cancer, were studied. PMID: 25729968
- ZNF217 has an oncogenic role in colorectal cancer and is regulated by miR-203. PMID: 25621839
- we conclude that ZNF217 may contribute to ovarian cancer invasion and metastasis, and associated with worse clinical outcomes. PMID: 25031722
- Synergic effects of loss of ARID1A and PI3K-Akt pathway activation as well as ZNF217 amplification may be related to the development of ovarian clear cell carcinoma. PMID: 24336158
- ERalpha expression highly correlates with ZNF217 in lysates from breast tumors. PMID: 24962896
- ZNF217 expression seems to be a novel prognostic biomarker in gastric cancer. PMID: 25202062
- Study investigated nested regulatory circuits of miR-200c/ZEB1 and miR-200c/ZNF217/TGF-beta/ZEB1 in synergistically promoting trastuzumab resistance and metastasis of breast cancer cells. PMID: 24615544
- New insights into DNA recognition by zinc fingers revealed by structural analysis of the oncoprotein ZNF217. PMID: 23436653
- downregulation of miR-24ZNF17 in prostate cancer (PCa) corresponds to an upregulation of ZNF217; ZNF217 could be identified as an oncogene because it is overexpressed in prostate cancer (PCa) and affects the growth of PCa cell lines PMID: 22815235
- Data suggest that the transcription factor ZNF217 is a biomarker of poor prognosis and a therapeutic target in patients with breast cancer. PMID: 22728437
- study showed that high levels of expression of ZNF217 mRNA are associated with poor prognosis and the development of metastases in breast cancer; ZNF217 also promoted epithelial-mesenchymal transition (EMT) in mammary epithelial cells PMID: 22593193
- found ZNF217 gene amplification to be significantly correlated with lymph node metastasis (p<0.05) in ovarian clear cell carcinoma. Profound inhibition of cell migration and invasion was observed in siRNA-treated cells with ZNF217 amplification PMID: 22843878
- These findings indicate that ZNF217 overexpression is critical to growth and survival of OCCCs with ZNF217 gene amplification. PMID: 22139760
- multi-zinc finger protein ZNF217 contacts DNA through a two-finger domain PMID: 21908891
- ZNF217 is overexpressed in GBMs and contributes to the maintenance of GSCs, which is regulated by HIFs released by the hypoxic environment of the tumor PMID: 21483406
- Data suggest that ZNF217 might play an important role in breast neoplastic progression and chemoresistance, and that Aurora-A might be involved in ZNF217-mediated effects. PMID: 21059223
- results show that ZNF217 regulates ErbB3 expression PMID: 20661224
- ZNF217 amplification was associated with medullary breast cancer. PMID: 20429623
- ZNF217 can be an important candidate gene responsible for the occurrence and progression of ovarian carcinomas. PMID: 19403395
- c-MYC amplification is an early event in breast cancer progression, while ZNF217 and Her2/neu amplification may play a role in the later stage of tumor development PMID: 15756435
- ZNF217 may promote neoplastic transformation by increasing cell survival during telomeric crisis and may promote later stages of malignancy by increasing cell survival during chemotherapy. PMID: 16203743
- These results identify a new CtBP interaction motif and establish ZNF217 as a transcriptional repressor protein that functions, at least in part, by associating with CtBP. PMID: 16940172
- implicate ZNF217 and its associated proteins in a novel pathway that may have profound effects on cancer progression PMID: 17130829
- ZNF217 and its associated pathways may provide new targets for therapeutic intervention in human cancers.[REVIEW] PMID: 17572303
- Suggest that ZNF217 might play a crucial role in the proliferation and invasion of ovarian cancer. PMID: 18425333
- These results establish the ZNF217 complex as a novel negative regulator of the p15(ink4b) gene and may constitute an important link between amplification of ZNF217 and the loss of TGF-beta responsiveness in breast cancer. PMID: 18625718
- ZNF217 assembles a distinct set of histone modifying proteins at target DNA sites that act synergistically in transcriptional repression. PMID: 19242095
顯示更多
收起更多
-
亞細(xì)胞定位:Nucleus.
-
蛋白家族:Krueppel C2H2-type zinc-finger protein family
-
數(shù)據(jù)庫(kù)鏈接:
Most popular with customers
-
-
YWHAB Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC, IF, FC
Species Reactivity: Human, Mouse, Rat
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-















